NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

全球放射治療市場:行業趨勢和預測(∼2027年)

Global Radiotherapy Market - Industry Trends and Forecast To 2027

出版商 Data Bridge Market Research Private Limited 商品編碼 961959
出版日期 內容資訊 英文 479 Pages
商品交期: 3-5個工作天內
價格
全球放射治療市場:行業趨勢和預測(∼2027年) Global Radiotherapy Market - Industry Trends and Forecast To 2027
出版日期: 2020年08月01日內容資訊: 英文 479 Pages
簡介

在2020年至2027年的預測期內,預計全球放射療法市場將保持5.7%的複合年增長率。

本報告調查了全球放射治療市場,並提供了市場概況和動態,按細分市場和地區進行的市場規模分析和預測,以及主要公司的概況。

第1章簡介

第2章市場細分

第3章執行摘要

第4章重要注意事項

  • 全球放射治療市場:市場佔有率分析
    • 市場佔有率分析:全球
    • 市場佔有率分析:北美
    • 市場佔有率分析:歐洲
    • 市場佔有率分析:亞太地區
    • 市場佔有率分析:南美
    • 市場佔有率分析:中東/非洲
  • 全球放射治療中的質子束治療市場:公司狀況
    • 企業佔有率分析:全球
    • 企業佔有率分析:北美
    • 企業佔有率分析:歐洲
    • 企業佔有率分析:亞太地區
  • 全球放射治療中的圖像引導放射治療(IGRT)市場:公司情況
    • 企業佔有率分析:全球
    • 企業佔有率分析:北美
    • 企業佔有率分析:歐洲
    • 企業佔有率分析:亞太地區
  • 小型放射源的全球放射治療市場:公司狀況
    • 企業佔有率分析:全球
    • 企業佔有率分析:北美
    • 企業佔有率分析:歐洲
    • 企業佔有率分析:亞太地區
  • 全球放射治療中的立體定向放射治療市場:公司狀況
    • 企業佔有率分析:全球
    • 企業佔有率分析:北美
    • 企業佔有率分析:歐洲
    • 企業佔有率分析:亞太地區

第5章COVID-19對世界市場的影響

  • 對需求的影響分析
  • 結論

第6章市場概述

  • 促進因素
    • 癌症疾病的患病率上升
    • 放射治療癌症新技術
    • 越來越多地採用放射治療設備和程序
    • 提高非手術程序的優先級
  • 抑制因素
    • 缺乏熟練和合格的專業人員
    • 放射治療的複雜性
    • 放射治療成本高
  • 市場機會
    • 增加的癌症醫療費用
    • 擴大政府的癌症治療計劃
    • 提高患者對癌症治療的認識
  • 挑戰
    • 放射治療產品批准和商業化的嚴格法規和標準
    • 輻射風險

第7章全球放射治療市場:按類型

  • 概述
  • 體外放射治療
    • 圖像引導放射治療(IGRT)
    • 質子束處理
    • 立體定向放射療法
    • 調強放射治療(IMRT)
    • 3D保形輻射(3D-CRT)
    • 強度調製旋轉輻照法(VMAT)
    • 其他
  • 內部放射療法
    • 小源治療
    • 選擇性內部放射療法(SIRT)
    • 小源治療
  • 全身放射線療/放射性藥物
  • 其他

第8章全球放射治療市場:副產品

  • 概述
  • 體外放射治療
    • 直線加速器
    • 質子束處理
    • 網絡刀
    • 伽瑪刀
    • 其他
  • 內部放射治療產品
    • 種子
    • 後裝載器
    • 其他
  • 放射治療軟件
    • 圖像引導軟件
    • 治療計劃軟件
    • 患者定位軟件
    • 劑量計劃軟件
    • 其他

第9章全球放射療法市場:按應用

  • 概述
  • 乳腺癌
  • 肺癌
  • 前列腺癌
  • 結腸癌和直腸癌
  • 淋巴瘤
  • 肝癌
  • 甲狀腺癌
  • 腦瘤
  • 宮頸癌
  • 脊柱癌
  • 其他

第10章全球放射療法市場:按最終用戶

  • 概述
  • 醫院
  • 放射治療中心
  • 專科診所
  • 其他

第11章全球放射治療市場:按分銷渠道

  • 概述
  • 直接出價
  • 零售
  • 其他

第12章全球放射治療市場:按地區

  • 概述
  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 法國
    • 意大利
    • 英國
    • 西班牙
    • 俄羅斯
    • 荷蘭
    • 瑞士
    • 比利時
    • 土耳其
    • 烏克蘭
    • 其他歐洲
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳大利亞
    • 韓國
    • 印度尼西亞
    • 泰國
    • 新加坡
    • 馬來西亞
    • 菲律賓
    • 其他亞太地區
  • 南美洲
    • 巴西
    • 阿根廷
    • 智利
    • 其他南美
  • 中東和非洲
    • 南非
    • 沙特阿拉伯
    • 阿拉伯聯合酋長國
    • 埃及
    • 以色列
    • 其他中東和非洲

第13章全球放射治療市場:公司狀況

  • 企業佔有率分析:全球
  • 企業佔有率分析:北美
  • 企業佔有率分析:歐洲
  • 企業佔有率分析:亞太地區

第14章SWOT分析

第15章公司簡介

  • VARIAN MEDICAL SYSTEMS, INC.
  • ELEKTA AB
  • SIEMENS HEALTHCARE GMBH
  • GE HEALTHCARE
  • ACCURAY INCORPORATED
  • KONINKLIJKE PHILIPS N.V.
  • ADVANCED ACCELERATOR APPLICATIONS (A SUBSIDIARY OF NOVARTIS AG)
  • BRAINLAB AG
  • CIVCO RADIOTHERAPY (A SUBSIDIARY OF ROPER TECHNOLOGIES, INC.)
  • ECKERT & ZIEGLER BEBIG
  • HITACHI, LTD.
  • IBA WORLDWIDE
  • ISORAY INC.
  • MEVION MEDICAL SYSTEMS
  • NORDION (CANADA) INC.
  • PROTOM INTERNATIONAL
  • PROVISION HEALTHCARE
  • RAYSEARCH LABORATORIES
  • SUMITOMO HEAVY INDUSTRIES, LTD.
  • VIEWRAY TECHNOLOGIES, INC. (A SUBSIDIARY OF VIEWRAY)

第16章調查表

第17章相關報告

目錄

Global radiotherapy market is projected to register a CAGR of 5.7% in the forecast period of 2020 to 2027. The new market report contains data for historic year 2018, the base year of calculation is 2019 and the forecast period is 2020 to 2027.

Market Segmentation:

Global Radiotherapy Market, By Type (External-Beam Radiation Therapy, Internal Radiation Therapy, Systemic Radiotherapy/Radiopharmaceuticals and Others), Product (External Beam Radiotherapy, Internal Radiotherapy Products, Radiotherapy Software and Others), Application (Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Lymphoma, Liver Cancer, Thyroid Cancer, Brain Cancer, Cervical Cancer, Spine Cancer and Others), End User (Hospitals, Radiation Therapy Centers, Specialty Clinics and Others), Distribution Channel (Direct Tender, Retail Sales and Others), Country (U.S., Canada & Mexico, Germany, U.K., France, Italy, Spain, Switzerland, Netherlands, Belgium, Russia, Turkey, Ukraine, Rest of Europe, Japan, China, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Chile, Rest of South America, South Africa, Saudi Arabia, UAE, Israel, Egypt and Rest of Middle East and Africa) Industry Trends and Forecast to 2027.

Some of the major factors contributing to the growth of the global radiotherapy market are:

  • Increasing cases of cancer disease across the word
  • Technology advancement in the radiotherapy treatment

Market Players:

The key market players for global radiotherapy market are listed below:

  • Varian Medical Systems, Inc.
  • ProTom International
  • Mevion Medical Systems
  • VIEWRAY TECHNOLOGIES, INC. (a subsidiary of ViewRay)
  • Siemens Healthcare GmbH
  • Elekta AB
  • Accuray Incorporated
  • IBA Worldwide
  • Eckert & Ziegler BEBIG
  • RaySearch Laboratories
  • Brainlab AG
  • Koninklijke Philips N.V.
  • GE Healthcare
  • Hitachi, Ltd.
  • Advanced Accelerator Applications (a subsidiary of Novartis AG)
  • Provision Healthcare.
  • Nordion (Canada) Inc.
  • Sumitomo Heavy Industries, Ltd.
  • CIVCO Radiotherapy (a subsidiary of Roper Technologies)
  • Isoray Inc
  • Nordion (Canada) Inc.
  • Sumitomo Heavy Industries, Ltd.
  • CIVCO Radiotherapy (A Subsidiary of Roper Technologies)
  • Isoray Inc

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
  • 1.3 OVERVIEW OF GLOBAL RADIOTHERAPY MARKET
  • 1.4 LIMITATIONS
  • 1.5 MARKETS COVERED

2 MARKET SEGMENTATION

  • 2.1 MARKETS COVERED
  • 2.2 GEOGRAPHICAL SCOPE
  • 2.3 YEARS CONSIDERED FOR THE STUDY
  • 2.4 CURRENCY AND PRICING
  • 2.5 DBMR TRIPOD DATA VALIDATION MODEL
  • 2.6 MULTIVARIATE MODELLING
  • 2.7 TYPE LIFELINE CURVE
  • 2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
  • 2.9 DBMR MARKET POSITION GRID
  • 2.10 MARKET APPLICATION COVERAGE GRID
  • 2.11 VENDOR SHARE ANALYSIS
  • 2.12 SECONDARY SOURCES
  • 2.13 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 GLOBAL RADIOTHERAPY MARKET, MARKET SHARE ANALYSIS
    • 4.1.1 MARKET SHARE ANALYSIS: GLOBAL
    • 4.1.2 MARKET SHARE ANALYSIS: NORTH AMERICA
      • 4.1.2.1 MARKET SHARE ANALYSIS: U.S.
      • 4.1.2.2 MARKET SHARE ANALYSIS: CANADA
      • 4.1.2.3 MARKET SHARE ANALYSIS: MEXICO
    • 4.1.3 MARKET SHARE ANALYSIS: EUROPE
      • 4.1.3.1 MARKET SHARE ANALYSIS: GERMANY
      • 4.1.3.2 MARKET SHARE ANALYSIS: FRANCE
      • 4.1.3.3 MARKET SHARE ANALYSIS: ITALY
      • 4.1.3.4 MARKET SHARE ANALYSIS: U.K.
      • 4.1.3.5 MARKET SHARE ANALYSIS: SPAIN
      • 4.1.3.6 MARKET SHARE ANALYSIS: RUSSIA
      • 4.1.3.7 MARKET SHARE ANALYSIS: NETHERLANDS
      • 4.1.3.8 MARKET SHARE ANALYSIS: SWITZERLAND
      • 4.1.3.9 MARKET SHARE ANALYSIS: BELGIUM
      • 4.1.3.10 MARKET SHARE ANALYSIS: TURKEY
      • 4.1.3.11 MARKET SHARE ANALYSIS: UKRAINE
    • 4.1.4 MARKET SHARE ANALYSIS: ASIA-PACIFIC
      • 4.1.4.1 MARKET SHARE ANALYSIS: CHINA
      • 4.1.4.2 MARKET SHARE ANALYSIS: JAPAN
      • 4.1.4.3 MARKET SHARE ANALYSIS: INDIA
      • 4.1.4.4 MARKET SHARE ANALYSIS: AUSTRALIA
      • 4.1.4.5 MARKET SHARE ANALYSIS: SOUTH KOREA
      • 4.1.4.6 MARKET SHARE ANALYSIS: INDONESIA
      • 4.1.4.7 MARKET SHARE ANALYSIS: THAILAND
      • 4.1.4.8 MARKET SHARE ANALYSIS: SINGAPORE
      • 4.1.4.9 MARKET SHARE ANALYSIS: MALAYSIA
      • 4.1.4.10 MARKET SHARE ANALYSIS: PHILIPPINES
    • 4.1.5 MARKET SHARE ANALYSIS: SOUTH AMERICA
      • 4.1.5.1 MARKET SHARE ANALYSIS: BRAZIL
      • 4.1.5.2 MARKET SHARE ANALYSIS: ARGENTINA
      • 4.1.5.3 MARKET SHARE ANALYSIS: CHILE
    • 4.1.6 MARKET SHARE ANALYSIS: MIDDLE EAST AND AFRICA
      • 4.1.6.1 MARKET SHARE ANALYSIS: SOUTH AFRICA
      • 4.1.6.2 MARKET SHARE ANALYSIS: SAUDI ARABIA
      • 4.1.6.3 MARKET SHARE ANALYSIS: UAE
      • 4.1.6.4 MARKET SHARE ANALYSIS: EGYPT
      • 4.1.6.5 MARKET SHARE ANALYSIS: ISRAEL
  • 4.2 GLOBAL PROTON BEAM THERAPY IN RADIOTHERAPY MARKET, COMPANY LANDSCAPE
    • 4.2.1 COMPANY SHARE ANALYSIS: GLOBAL
    • 4.2.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
      • 4.2.2.1 COMPANY SHARE ANALYSIS: U.S.
      • 4.2.2.2 COMPANY SHARE ANALYSIS: CANADA
    • 4.2.3 COMPANY SHARE ANALYSIS: EUROPE
      • 4.2.3.1 COMPANY SHARE ANALYSIS: GERMANY
      • 4.2.3.2 COMPANY SHARE ANALYSIS: FRANCE
      • 4.2.3.3 COMPANY SHARE ANALYSIS: ITALY
      • 4.2.3.4 COMPANY SHARE ANALYSIS: U.K.
      • 4.2.3.5 COMPANY SHARE ANALYSIS: SPAIN
    • 4.2.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
      • 4.2.4.1 company share analysis: CHINA
      • 4.2.4.2 COMPANY SHARE ANALYSIS: JAPAN
      • 4.2.4.3 COMPANY SHARE ANALYSIS: INDIA
      • 4.2.4.4 COMPANY SHARE ANALYSIS: SOUTH KOREA
  • 4.3 GLOBAL BRACHYTHERAPY IN RADIOTHERAPY MARKET, COMPANY LANDSCAPE
    • 4.3.1 COMPANY SHARE ANALYSIS: GLOBAL
    • 4.3.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
      • 4.3.2.1 COMPANY SHARE ANALYSIS: U.S.
      • 4.3.2.2 COMPANY SHARE ANALYSIS: CANADA
    • 4.3.3 COMPANY SHARE ANALYSIS: EUROPE
      • 4.3.3.1 COMPANY SHARE ANALYSIS: GERMANY
      • 4.3.3.2 COMPANY SHARE ANALYSIS: FRANCE
      • 4.3.3.3 COMPANY SHARE ANALYSIS: ITALY
      • 4.3.3.4 COMPANY SHARE ANALYSIS: U.K.
      • 4.3.3.5 COMPANY SHARE ANALYSIS: SPAIN
    • 4.3.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
      • 4.3.4.1 COMPANY SHARE ANALYSIS: CHINA
      • 4.3.4.2 COMPANY SHARE ANALYSIS: JAPAN
      • 4.3.4.3 COMPANY SHARE ANALYSIS: INDIA
      • 4.3.4.4 COMPANY SHARE ANALYSIS: SOUTH KOREA
  • 4.4 GLOBAL IMAGE-GUIDED RADIATION THERAPY (IGRT) IN RADIOTHERAPY MARKET, COMPANY LANDSCAPE
    • 4.4.1 COMPANY SHARE ANALYSIS: GLOBAL
    • 4.4.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
      • 4.4.2.1 COMPANY SHARE ANALYSIS: U.S.
      • 4.4.2.2 COMPANY SHARE ANALYSIS: CANADA
    • 4.4.3 COMPANY SHARE ANALYSIS: EUROPE
      • 4.4.3.1 COMPANY SHARE ANALYSIS: GERMANY
      • 4.4.3.2 COMPANY SHARE ANALYSIS: FRANCE
      • 4.4.3.3 COMPANY SHARE ANALYSIS: ITALY
      • 4.4.3.4 COMPANY SHARE ANALYSIS: U.K.
      • 4.4.3.5 COMPANY SHARE ANALYSIS: SPAIN
    • 4.4.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
      • 4.4.4.1 COMPANY SHARE ANALYSIS: CHINA
      • 4.4.4.2 COMPANY SHARE ANALYSIS: JAPAN
      • 4.4.4.3 COMPANY SHARE ANALYSIS: INDIA
      • 4.4.4.4 COMPANY SHARE ANALYSIS: SOUTH KOREA
  • 4.5 GLOBAL STEREOTACTIC RADIATION THERAPY IN RADIOTHERAPY MARKET, COMPANY LANDSCAPE
    • 4.5.1 COMPANY SHARE ANALYSIS: GLOBAL
    • 4.5.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
      • 4.5.2.1 COMPANY SHARE ANALYSIS: U.S.
      • 4.5.2.2 COMPANY SHARE ANALYSIS: CANADA
    • 4.5.3 COMPANY SHARE ANALYSIS: EUROPE
      • 4.5.3.1 COMPANY SHARE ANALYSIS: GERMANY
      • 4.5.3.2 COMPANY SHARE ANALYSIS: FRANCE
      • 4.5.3.3 COMPANY SHARE ANALYSIS: ITALY
      • 4.5.3.4 COMPANY SHARE ANALYSIS: U.K.
      • 4.5.3.5 COMPANY SHARE ANALYSIS: SPAIN
    • 4.5.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
      • 4.5.4.1 COMPANY SHARE ANALYSIS: CHINA
      • 4.5.4.2 COMPANY SHARE ANALYSIS: JAPAN
      • 4.5.4.3 COMPANY SHARE ANALYSIS: INDIA
      • 4.5.4.4 COMPANY SHARE ANALYSIS: SOUTH KOREA

5 IMPACT OF COVID-19 ON GLOBAL RADIOTHERAPY MARKET

  • 5.1 IMPACT ANALYSIS ON DEMAND
  • 5.2 CONCLUSION

6 MARKET OVERVIEW

  • 6.1 DRIVERS
    • 6.1.1 GROWING PREVALENCE OF CANCER DISEASE
    • 6.1.2 NOVEL TECHNOLOGY IN RADIOTHERAPY FOR CANCER TREATMENT
    • 6.1.3 INCREASING ADOPTION OF RADIOTHERAPY DEVICES AND PROCEDURES
    • 6.1.4 RISING PREFERENCE FOR NON-SURGICAL PROCEDURES
  • 6.2 RESTRAINTS
    • 6.2.1 LACK OF SKILLED AND CERTIFIED PROFESSIONALS
    • 6.2.2 COMPLEX NATURE OF RADIOTHERAPY
    • 6.2.3 HIGH COST OF RADIOTHERAPY PROCEDURES
  • 6.3 OPPORTUNITIES
    • 6.3.1 INCREASING HEALTHCARE EXPENDITURES FOR CANCER TREATMENTS
    • 6.3.2 GROWING GOVERNMENT INITIATIVES TOWARDS CANCER TREATMENT
    • 6.3.3 RISING PATIENTS AWARENESS TOWARDS CANCER TREATMENT
  • 6.4 CHALLENGES
    • 6.4.1 STRICT REGULATIONS AND STANDARDS FOR THE APPROVAL AND COMMERCIALIZATION OF RADIOTHERAPY PRODUCTS
    • 6.4.2 RISK OF RADIATION EXPOSURE

7 GLOBAL RADIOTHERAPY MARKET, BY TYPE

  • 7.1 OVERVIEW
  • 7.2 EXTERNAL-BEAM RADIATION THERAPY
    • 7.2.1 IMAGE-GUIDED RADIATION THERAPY (IGRT)
    • 7.2.2 PROTON BEAM THERAPY
    • 7.2.3 STEREOTACTIC RADIATION THERAPY
    • 7.2.4 INTENSITY MODULATED RADIATION THERAPY (IMRT)
    • 7.2.5 THREE-DIMENSIONAL CONFORMAL RADIATION THERAPY (3D-CRT)
    • 7.2.6 VOLUMETRIC MODULATED ARC THERAPY (VMAT)
    • 7.2.7 OTHERS
  • 7.3 INTERNAL RADIATION THERAPY
    • 7.3.1 BRACHYTHERAPY
    • 7.3.2 SELECTIVE INTERNAL RADIATION THERAPY (SIRT)
    • 7.3.3 BRACHYTHERAPY
      • 7.3.3.1 HIGH DOSE BRACHYTHERAPY
      • 7.3.3.2 LOW DOSE BRACHYTHERAPY
  • 7.4 SYSTEMIC RADIOTHERAPY/ RADIOPHARMACEUTICALS
  • 7.5 OTHERS

8 GLOBAL RADIOTHERAPY MARKET, BY PRODUCT

  • 8.1 OVERVIEW
  • 8.2 EXTERNAL BEAM RADIOTHERAPY
    • 8.2.1 LINAC
    • 8.2.2 PROTON THERAPY
    • 8.2.3 CYBER KNIFE
    • 8.2.4 GAMMA KNIFE
    • 8.2.5 OTHERS
  • 8.3 INTERNAL RADIOTHERAPY PRODUCTS
    • 8.3.1 SEEDS
    • 8.3.2 AFTERLOADERS
    • 8.3.3 OTHERS
  • 8.4 RADIOTHERAPY SOFTWARE
    • 8.4.1 IMAGE GUIDING SOFTWARE
    • 8.4.2 TREATMENT PLANNING SOFTWARE
    • 8.4.3 PATIENT POSITIONING SOFTWARE
    • 8.4.4 DOSAGE PLANNING SOFTWARE
    • 8.4.5 OTHERS

9 GLOBAL RADIOTHERAPY MARKET, BY APPLICATION

  • 9.1 OVERVIEW
  • 9.2 BREAST CANCER
  • 9.3 LUNG CANCER
  • 9.4 PROSTATE CANCER
  • 9.5 COLORECTAL CANCER
  • 9.6 LYMPHOMA
  • 9.7 LIVER CANCER
  • 9.8 THYROID CANCER
  • 9.9 BRAIN CANCER
  • 9.10 CERVICAL CANCER
  • 9.11 SPINE CANCER
  • 9.12 OTHERS

10 GLOBAL RADIOTHERAPY MARKET, BY END USER

  • 10.1 OVERVIEW
  • 10.2 HOSPITALS
  • 10.3 RADIATION THERAPY CENTERS
  • 10.4 SPECIALTY CLINICS
  • 10.5 OTHERS

11 GLOBAL RADIOTHERAPY MARKET, BY DISTRIBUTION CHANNEL

  • 11.1 OVERVIEW
  • 11.2 DIRECT TENDER
  • 11.3 RETAIL SALES
  • 11.4 OTHERS

12 GLOBAL RADIOTHERAPY MARKET, BY GEOGRAPHY

  • 12.1 OVERVIEW
  • 12.2 NORTH AMERICA
    • 12.2.1 U.S.
    • 12.2.2 CANADA
    • 12.2.3 MEXICO
  • 12.3 EUROPE
    • 12.3.1 GERMANY
    • 12.3.2 FRANCE
    • 12.3.3 ITALY
    • 12.3.4 U.K.
    • 12.3.5 SPAIN
    • 12.3.6 RUSSIA
    • 12.3.7 NETHERLANDS
    • 12.3.8 SWITZERLAND
    • 12.3.9 BELGIUM
    • 12.3.10 TURKEY
    • 12.3.11 UKRAINE
    • 12.3.12 REST OF EUROPE
  • 12.4 ASIA-PACIFIC
    • 12.4.1 CHINA
    • 12.4.2 JAPAN
    • 12.4.3 INDIA
    • 12.4.4 AUSTRALIA
    • 12.4.5 SOUTH KOREA
    • 12.4.6 INDONESIA
    • 12.4.7 THAILAND
    • 12.4.8 SINGAPORE
    • 12.4.9 MALAYSIA
    • 12.4.10 PHILIPPINES
    • 12.4.11 REST OF ASIA-PACIFIC
  • 12.5 SOUTH AMERICA
    • 12.5.1 BRAZIL.
    • 12.5.2 ARGENTINA
    • 12.5.3 CHILE
    • 12.5.4 REST OF SOUTH AMERICA
  • 12.6 MIDDLE EAST AND AFRICA
    • 12.6.1 SOUTH AFRICA
    • 12.6.2 SAUDI ARABIA
    • 12.6.3 UAE
    • 12.6.4 EGYPT
    • 12.6.5 ISRAEL
    • 12.6.6 REST OF MIDDLE EAST AND AFRICA

13 GLOBAL RADIOTHERAPY MARKET, COMPANY LANDSCAPE

  • 13.1 COMPANY SHARE ANALYSIS: GLOBAL
  • 13.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
  • 13.3 COMPANY SHARE ANALYSIS: EUROPE
  • 13.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC

14 SWOT ANALYSIS

15 COMPANY PROFILE

  • 15.1 VARIAN MEDICAL SYSTEMS, INC.
    • 15.1.1 COMPANY SNAPSHOT
    • 15.1.2 REVENUE ANALYSIS
    • 15.1.3 COMPANY SHARE ANALYSIS
    • 15.1.4 PRODUCT PORTFOLIO
    • 15.1.5 RECENT DEVELOPMENTS
  • 15.2 ELEKTA AB
    • 15.2.1 COMPANY SNAPSHOT
    • 15.2.2 REVENUE ANALYSIS
    • 15.2.3 COMPANY SHARE ANALYSIS
    • 15.2.4 PRODUCT PORTFOLIO
    • 15.2.5 RECENT DEVELOPMENTS
  • 15.3 SIEMENS HEALTHCARE GMBH
    • 15.3.1 COMPANY SNAPSHOT
    • 15.3.2 REVENUE ANALYSIS
    • 15.3.3 COMPANY SHARE ANALYSIS
    • 15.3.4 PRODUCT PORTFOLIO
    • 15.3.5 RECENT DEVELOPMENTS
  • 15.4 GE HEALTHCARE
    • 15.4.1 COMPANY SNAPSHOT
    • 15.4.2 REVENUE ANALYSIS
    • 15.4.3 COMPANY SHARE ANALYSIS
    • 15.4.4 PRODUCT PORTFOLIO
    • 15.4.5 RECENT DEVELOPMENT
  • 15.5 ACCURAY INCORPORATED
    • 15.5.1 COMPANY SNAPSHOT
    • 15.5.2 REVENUE ANALYSIS
    • 15.5.3 COMPANY SHARE ANALYSIS
    • 15.5.4 PRODUCT PORTFOLIO
    • 15.5.5 RECENT DEVELOPMENT
  • 15.6 KONINKLIJKE PHILIPS N.V.
    • 15.6.1 COMPANY SNAPSHOT
    • 15.6.2 REVENUE ANALYSIS
    • 15.6.3 PRODUCT PORTFOLIO
    • 15.6.4 RECENT DEVELOPMENTS
  • 15.7 ADVANCED ACCELERATOR APPLICATIONS (A SUBSIDIARY OF NOVARTIS AG)
    • 15.7.1 COMPANY SNAPSHOT
    • 15.7.2 REVENUE ANALYSIS
    • 15.7.3 PRODUCT PORTFOLIO
    • 15.7.4 RECENT DEVELOPMENT
  • 15.8 BRAINLAB AG
    • 15.8.1 COMPANY SNAPSHOT
    • 15.8.2 PRODUCT PORTFOLIO
    • 15.8.3 RECENT DEVELOPMENT
  • 15.9 CIVCO RADIOTHERAPY (A SUBSIDIARY OF ROPER TECHNOLOGIES, INC.)
    • 15.9.1 COMPANY SNAPSHOT
    • 15.9.2 REVENUE ANALYSIS
    • 15.9.3 PRODUCT PORTFOLIO
    • 15.9.4 RECENT DEVELOPMENT
  • 15.10 ECKERT & ZIEGLER BEBIG
    • 15.10.1 COMPANY SNAPSHOT
    • 15.10.2 REVENUE ANALYSIS
    • 15.10.3 PRODUCT PORTFOLIO
    • 15.10.4 RECENT DEVELOPMENT
  • 15.11 HITACHI, LTD.
    • 15.11.1 COMPANY SNAPSHOT
    • 15.11.2 REVENUE ANALYSIS
    • 15.11.3 PRODUCT PORTFOLIO
    • 15.11.4 RECENT DEVELOPMENT
  • 15.12 IBA WORLDWIDE
    • 15.12.1 COMPANY SNAPSHOT
    • 15.12.2 REVENUE ANALYSIS
    • 15.12.3 PRODUCT PORTFOLIO
    • 15.12.4 RECENT DEVELOPMENT
  • 15.13 ISORAY INC.
    • 15.13.1 COMPANY SNAPSHOT
    • 15.13.2 REVENUE ANALYSIS
    • 15.13.3 PRODUCT PORTFOLIO
    • 15.13.4 RECENT DEVELOPMENT
  • 15.14 MEVION MEDICAL SYSTEMS
    • 15.14.1 COMPANY SNAPSHOT
    • 15.14.2 PRODUCT PORTFOLIO
    • 15.14.3 RECENT DEVELOPMENT
  • 15.15 NORDION (CANADA) INC.
    • 15.15.1 COMPANY SNAPSHOT
    • 15.15.2 PRODUCT PORTFOLIO
    • 15.15.3 RECENT DEVELOPMENT
  • 15.16 PROTOM INTERNATIONAL
    • 15.16.1 COMPANY SNAPSHOT
    • 15.16.2 PRODUCT PORTFOLIO
    • 15.16.3 RECENT DEVELOPMENT
  • 15.17 PROVISION HEALTHCARE
    • 15.17.1 COMPANY SNAPSHOT
    • 15.17.2 SOLUTION PORTFOLIO
    • 15.17.3 RECENT DEVELOPMENT
  • 15.18 RAYSEARCH LABORATORIES
    • 15.18.1 COMPANY SNAPSHOT
    • 15.18.2 REVENUE ANALYSIS
    • 15.18.3 PRODUCT PORTFOLIO
    • 15.18.4 RECENT DEVELOPMENT
  • 15.19 SUMITOMO HEAVY INDUSTRIES, LTD.
    • 15.19.1 COMPANY SNAPSHOT
    • 15.19.2 REVENUE ANALYSIS
    • 15.19.3 PRODUCT PORTFOLIO
    • 15.19.4 RECENT DEVELOPMENT
  • 15.20 VIEWRAY TECHNOLOGIES, INC. (A SUBSIDIARY OF VIEWRAY)
    • 15.20.1 COMPANY SNAPSHOT
    • 15.20.2 REVENUE ANALYSIS
    • 15.20.3 PRODUCT PORTFOLIO
    • 15.20.4 RECENT DEVELOPMENT

16 QUESTIONNAIRE

17 RELATED REPORTS

LIST OF FIGURES

  • FIGURE 1 GLOBAL RADIOTHERAPY MARKET: SEGMENTATION
  • FIGURE 2 GLOBAL RADIOTHERAPY MARKET: DATA TRIANGULATION
  • FIGURE 3 GLOBAL RADIOTHERAPY MARKET: DROC ANALYSIS
  • FIGURE 4 GLOBAL RADIOTHERAPY MARKET : GLOBAL VS REGIONAL MARKET ANALYSIS
  • FIGURE 5 GLOBAL RADIOTHERAPY MARKET : COMPANY RESEARCH ANALYSIS
  • FIGURE 6 GLOBAL RADIOTHERAPY MARKET: INTERVIEW DEMOGRAPHICS
  • FIGURE 7 GLOBAL RADIOTHERAPY MARKET: DBMR MARKET POSITION GRID
  • FIGURE 8 GLOBAL RADIOTHERAPY MARKET: MARKET APPLICATION COVERAGE GRID
  • FIGURE 9 GLOBAL RADIOTHERAPY MARKET: VENDOR SHARE ANALYSIS
  • FIGURE 10 GLOBAL RADIOTHERAPY MARKET: SEGMENTATION
  • FIGURE 11 GROWING PREVALENCE OF CANCER DISEASE AND NOVEL TECHNOLOGY IN RADIOTHERAPY FOR CANCER TREATMENT ARE EXPECTED TO DRIVE THE GLOBAL RADIOTHERAPY MARKET IN THE FORECAST PERIOD OF 2020 TO 2027
  • FIGURE 12 EXTERNAL-BEAM RADIATION THERAPY SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL RADIOTHERAPY MARKET IN 2020 & 2027
  • FIGURE 13 NORTH AMERICA IS EXPECTED TO DOMINATE THE GLOBAL RADIOTHERAPY MARKET AND ASIA-PACIFIC IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2020 TO 2027
  • FIGURE 14 ASIA-PACIFIC IS THE FASTEST GROWING MARKET FOR RADIOTHERAPY MANUFACTURERS IN THE FORECAST PERIOD OF 2020 TO 2027
  • FIGURE 15 GLOBAL RADIOTHERAPY MARKET, BY PRODUCT: MARKET SHARE 2019 (%)
  • FIGURE 16 GLOBAL EXTERNAL BEAM RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT: MARKET SHARE 2019 (%)
  • FIGURE 17 GLOBAL INTERNAL RADIOTHERAPY PRODUCTS IN RADIOTHERAPY MARKET, BY PRODUCT: MARKET SHARE 2019 (%)
  • FIGURE 18 NORTH AMERICARADIOTHERAPY MARKET, BY PRODUCT: MARKET SHARE 2019 (%)
  • FIGURE 19 NORTH AMERICAEXTERNAL BEAM RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT: MARKET SHARE 2019 (%)
  • FIGURE 20 NORTH AMERICAINTERNAL RADIOTHERAPY PRODUCTS IN RADIOTHERAPY MARKET, BY PRODUCT: MARKET SHARE 2019 (%)
  • FIGURE 21 U.S. RADIOTHERAPY MARKET, BY PRODUCT: MARKET SHARE 2019 (%)
  • FIGURE 22 U.S. EXTERNAL BEAM RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT: MARKET SHARE 2019 (%)
  • FIGURE 23 U.S. INTERNAL RADIOTHERAPY PRODUCTS IN RADIOTHERAPY MARKET, BY PRODUCT: MARKET SHARE 2019 (%)
  • FIGURE 24 CANADA RADIOTHERAPY MARKET, BY PRODUCT: MARKET SHARE 2019 (%)
  • FIGURE 25 CANADA EXTERNAL BEAM RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT: MARKET SHARE 2019 (%)
  • FIGURE 26 CANADA INTERNAL RADIOTHERAPY PRODUCTS IN RADIOTHERAPY MARKET, BY PRODUCT: MARKET SHARE 2019 (%)
  • FIGURE 27 MEXICO RADIOTHERAPY MARKET, BY PRODUCT: MARKET SHARE 2019 (%)
  • FIGURE 28 MEXICO EXTERNAL BEAM RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT: MARKET SHARE 2019 (%)
  • FIGURE 29 MEXICO INTERNAL RADIOTHERAPY PRODUCTS IN RADIOTHERAPY MARKET, BY PRODUCT: MARKET SHARE 2019 (%)
  • FIGURE 30 EUROPE RADIOTHERAPY MARKET, BY PRODUCT: MARKET SHARE 2019 (%)
  • FIGURE 31 EUROPE EXTERNAL BEAM RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT: MARKET SHARE 2019 (%)
  • FIGURE 32 EUROPE INTERNAL RADIOTHERAPY PRODUCTS IN RADIOTHERAPY MARKET, BY PRODUCT: MARKET SHARE 2019 (%)
  • FIGURE 33 GERMANY RADIOTHERAPY MARKET, BY PRODUCT: MARKET SHARE 2019 (%)
  • FIGURE 34 GERMANY EXTERNAL BEAM RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT: MARKET SHARE 2019 (%)
  • FIGURE 35 GERMANY INTERNAL RADIOTHERAPY PRODUCTS IN RADIOTHERAPY MARKET, BY PRODUCT: MARKET SHARE 2019 (%)
  • FIGURE 36 FRANCE RADIOTHERAPY MARKET, BY PRODUCT: MARKET SHARE 2019 (%)
  • FIGURE 37 FRANCE EXTERNAL BEAM RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT: MARKET SHARE 2019 (%)
  • FIGURE 38 FRANCE INTERNAL RADIOTHERAPY PRODUCTS IN RADIOTHERAPY MARKET, BY PRODUCT: MARKET SHARE 2019 (%)
  • FIGURE 39 ITALY RADIOTHERAPY MARKET, BY PRODUCT: MARKET SHARE 2019 (%)
  • FIGURE 40 ITALY EXTERNAL BEAM RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT: MARKET SHARE 2019 (%)
  • FIGURE 41 ITALY INTERNAL RADIOTHERAPY PRODUCTS IN RADIOTHERAPY MARKET, BY PRODUCT: MARKET SHARE 2019 (%)
  • FIGURE 42 U.K. RADIOTHERAPY MARKET, BY PRODUCT: MARKET SHARE 2019 (%)
  • FIGURE 43 U.K. EXTERNAL BEAM RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT: MARKET SHARE 2019 (%)
  • FIGURE 44 U.K. INTERNAL RADIOTHERAPY PRODUCTS IN RADIOTHERAPY MARKET, BY PRODUCT: MARKET SHARE 2019 (%)
  • FIGURE 45 SPAIN RADIOTHERAPY MARKET, BY PRODUCT: MARKET SHARE 2019 (%)
  • FIGURE 46 SPAIN EXTERNAL BEAM RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT: MARKET SHARE 2019 (%)
  • FIGURE 47 SPAIN INTERNAL RADIOTHERAPY PRODUCTS IN RADIOTHERAPY MARKET, BY PRODUCT: MARKET SHARE 2019 (%)
  • FIGURE 48 RUSSIA RADIOTHERAPY MARKET, BY PRODUCT: MARKET SHARE 2019 (%)
  • FIGURE 49 RUSSIA EXTERNAL BEAM RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT: MARKET SHARE 2019 (%)
  • FIGURE 50 RUSSIA INTERNAL RADIOTHERAPY PRODUCTS IN RADIOTHERAPY MARKET, BY PRODUCT: MARKET SHARE 2019 (%)
  • FIGURE 51 NETHERLANDS RADIOTHERAPY MARKET, BY PRODUCT: MARKET SHARE 2019 (%)
  • FIGURE 52 NETHERLANDS EXTERNAL BEAM RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT: MARKET SHARE 2019 (%)
  • FIGURE 53 NETHERLANDS INTERNAL RADIOTHERAPY PRODUCTS IN RADIOTHERAPY MARKET, BY PRODUCT: MARKET SHARE 2019 (%)
  • FIGURE 54 SWITZERLAND RADIOTHERAPY MARKET, BY PRODUCT: MARKET SHARE 2019 (%)
  • FIGURE 55 SWITZERLAND EXTERNAL BEAM RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT: MARKET SHARE 2019 (%)
  • FIGURE 56 SWITZERLAND INTERNAL RADIOTHERAPY PRODUCTS IN RADIOTHERAPY MARKET, BY PRODUCT: MARKET SHARE 2019 (%)
  • FIGURE 57 BELGIUM RADIOTHERAPY MARKET, BY PRODUCT: MARKET SHARE 2019 (%)
  • FIGURE 58 BELGIUM EXTERNAL BEAM RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT: MARKET SHARE 2019 (%)
  • FIGURE 59 BELGIUM INTERNAL RADIOTHERAPY PRODUCTS IN RADIOTHERAPY MARKET, BY PRODUCT: MARKET SHARE 2019 (%)
  • FIGURE 60 TURKEY RADIOTHERAPY MARKET, BY PRODUCT: MARKET SHARE 2019 (%)
  • FIGURE 61 TURKEY EXTERNAL BEAM RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT: MARKET SHARE 2019 (%)
  • FIGURE 62 TURKEY INTERNAL RADIOTHERAPY PRODUCTS IN RADIOTHERAPY MARKET, BY PRODUCT: MARKET SHARE 2019 (%)
  • FIGURE 63 UKRAINE RADIOTHERAPY MARKET, BY PRODUCT: MARKET SHARE 2019 (%)
  • FIGURE 64 UKRAINE EXTERNAL BEAM RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT: MARKET SHARE 2019 (%)
  • FIGURE 65 UKRAINE INTERNAL RADIOTHERAPY PRODUCTS IN RADIOTHERAPY MARKET, BY PRODUCT: MARKET SHARE 2019 (%)
  • FIGURE 66 ASIA-PACIFIC RADIOTHERAPY MARKET, BY PRODUCT: MARKET SHARE 2019 (%)
  • FIGURE 67 ASIA-PACIFIC EXTERNAL BEAM RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT: MARKET SHARE 2019 (%)
  • FIGURE 68 ASIA-PACIFIC INTERNAL RADIOTHERAPY PRODUCTS IN RADIOTHERAPY MARKET, BY PRODUCT: MARKET SHARE 2019 (%)
  • FIGURE 69 CHINA RADIOTHERAPY MARKET, BY PRODUCT: MARKET SHARE 2019 (%)
  • FIGURE 70 CHINA EXTERNAL BEAM RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT: MARKET SHARE 2019 (%)
  • FIGURE 71 CHINA INTERNAL RADIOTHERAPY PRODUCTS IN RADIOTHERAPY MARKET, BY PRODUCT: MARKET SHARE 2019 (%)
  • FIGURE 72 JAPAN RADIOTHERAPY MARKET, BY PRODUCT: MARKET SHARE 2019 (%)
  • FIGURE 73 JAPAN EXTERNAL BEAM RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT: MARKET SHARE 2019 (%)
  • FIGURE 74 JAPAN INTERNAL RADIOTHERAPY PRODUCTS IN RADIOTHERAPY MARKET, BY PRODUCT: MARKET SHARE 2019 (%)
  • FIGURE 75 INDIA RADIOTHERAPY MARKET, BY PRODUCT: MARKET SHARE 2019 (%)
  • FIGURE 76 INDIA EXTERNAL BEAM RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT: MARKET SHARE 2019 (%)
  • FIGURE 77 INDIA INTERNAL RADIOTHERAPY PRODUCTS IN RADIOTHERAPY MARKET, BY PRODUCT: MARKET SHARE 2019 (%)
  • FIGURE 78 AUSTRALIA RADIOTHERAPY MARKET, BY PRODUCT: MARKET SHARE 2019 (%)
  • FIGURE 79 AUSTRALIA EXTERNAL BEAM RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT: MARKET SHARE 2019 (%)
  • FIGURE 80 AUSTRALIA INTERNAL RADIOTHERAPY PRODUCTS IN RADIOTHERAPY MARKET, BY PRODUCT: MARKET SHARE 2019 (%)
  • FIGURE 81 SOUTH KOREA RADIOTHERAPY MARKET, BY PRODUCT: MARKET SHARE 2019 (%)
  • FIGURE 82 SOUTH KOREA EXTERNAL BEAM RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT: MARKET SHARE 2019 (%)
  • FIGURE 83 SOUTH KOREA INTERNAL RADIOTHERAPY PRODUCTS IN RADIOTHERAPY MARKET, BY PRODUCT: MARKET SHARE 2019 (%)
  • FIGURE 84 INDONESIA RADIOTHERAPY MARKET, BY PRODUCT: MARKET SHARE 2019 (%)
  • FIGURE 85 INDONESIA EXTERNAL BEAM RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT: MARKET SHARE 2019 (%)
  • FIGURE 86 INDONESIA INTERNAL RADIOTHERAPY PRODUCTS IN RADIOTHERAPY MARKET, BY PRODUCT: MARKET SHARE 2019 (%)
  • FIGURE 87 THAILAND RADIOTHERAPY MARKET, BY PRODUCT: MARKET SHARE 2019 (%)
  • FIGURE 88 THAILAND EXTERNAL BEAM RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT: MARKET SHARE 2019 (%)
  • FIGURE 89 THAILAND INTERNAL RADIOTHERAPY PRODUCTS IN RADIOTHERAPY MARKET, BY PRODUCT: MARKET SHARE 2019 (%)
  • FIGURE 90 SINGAPORE RADIOTHERAPY MARKET, BY PRODUCT: MARKET SHARE 2019 (%)
  • FIGURE 91 SINGAPORE EXTERNAL BEAM RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT: MARKET SHARE 2019 (%)
  • FIGURE 92 SINGAPORE INTERNAL RADIOTHERAPY PRODUCTS IN RADIOTHERAPY MARKET, BY PRODUCT: MARKET SHARE 2019 (%)
  • FIGURE 93 MALAYSIA RADIOTHERAPY MARKET, BY PRODUCT: MARKET SHARE 2019 (%)
  • FIGURE 94 MALAYSIA EXTERNAL BEAM RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT: MARKET SHARE 2019 (%)
  • FIGURE 95 MALAYSIA INTERNAL RADIOTHERAPY PRODUCTS IN RADIOTHERAPY MARKET, BY PRODUCT: MARKET SHARE 2019 (%)
  • FIGURE 96 PHILIPPINES RADIOTHERAPY MARKET, BY PRODUCT: MARKET SHARE 2019 (%)
  • FIGURE 97 PHILIPPINES EXTERNAL BEAM RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT: MARKET SHARE 2019 (%)
  • FIGURE 98 PHILIPPINES INTERNAL RADIOTHERAPY PRODUCTS IN RADIOTHERAPY MARKET, BY PRODUCT: MARKET SHARE 2019 (%)
  • FIGURE 99 SOUTH AMERICA RADIOTHERAPY MARKET, BY PRODUCT: MARKET SHARE 2019 (%)
  • FIGURE 100 SOUTH AMERICA EXTERNAL BEAM RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT: MARKET SHARE 2019 (%)
  • FIGURE 101 SOUTH AMERICA INTERNAL RADIOTHERAPY PRODUCTS IN RADIOTHERAPY MARKET, BY PRODUCT: MARKET SHARE 2019 (%)
  • FIGURE 102 BRAZIL RADIOTHERAPY MARKET, BY PRODUCT: MARKET SHARE 2019 (%)
  • FIGURE 103 BRAZIL EXTERNAL BEAM RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT: MARKET SHARE 2019 (%)
  • FIGURE 104 BRAZIL INTERNAL RADIOTHERAPY PRODUCTS IN RADIOTHERAPY MARKET, BY PRODUCT: MARKET SHARE 2019 (%)
  • FIGURE 105 ARGENTINA RADIOTHERAPY MARKET, BY PRODUCT: MARKET SHARE 2019 (%)
  • FIGURE 106 ARGENTINA EXTERNAL BEAM RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT: MARKET SHARE 2019 (%)
  • FIGURE 107 ARGENTINA INTERNAL RADIOTHERAPY PRODUCTS IN RADIOTHERAPY MARKET, BY PRODUCT: MARKET SHARE 2019 (%)
  • FIGURE 108 CHILE RADIOTHERAPY MARKET, BY PRODUCT: MARKET SHARE 2019 (%)
  • FIGURE 109 CHILE EXTERNAL BEAM RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT: MARKET SHARE 2019 (%)
  • FIGURE 110 CHILE INTERNAL RADIOTHERAPY PRODUCTS IN RADIOTHERAPY MARKET, BY PRODUCT: MARKET SHARE 2019 (%)
  • FIGURE 111 MIDDLE EAST AND AFRICA RADIOTHERAPY MARKET, BY PRODUCT: MARKET SHARE 2019 (%)
  • FIGURE 112 MIDDLE EAST AND AFRICA EXTERNAL BEAM RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT: MARKET SHARE 2019 (%)
  • FIGURE 113 MIDDLE EAST AND AFRICA INTERNAL RADIOTHERAPY PRODUCTS IN RADIOTHERAPY MARKET, BY PRODUCT: MARKET SHARE 2019 (%)
  • FIGURE 114 SOUTH AFRICA RADIOTHERAPY MARKET, BY PRODUCT: MARKET SHARE 2019 (%)
  • FIGURE 115 SOUTH AFRICA EXTERNAL BEAM RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT: MARKET SHARE 2019 (%)
  • FIGURE 116 SOUTH AFRICA INTERNAL RADIOTHERAPY PRODUCTS IN RADIOTHERAPY MARKET, BY PRODUCT: MARKET SHARE 2019 (%)
  • FIGURE 117 SAUDI ARABIA RADIOTHERAPY MARKET, BY PRODUCT: MARKET SHARE 2019 (%)
  • FIGURE 118 SAUDI ARABIA EXTERNAL BEAM RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT: MARKET SHARE 2019 (%)
  • FIGURE 119 SAUDI ARABIA INTERNAL RADIOTHERAPY PRODUCTS IN RADIOTHERAPY MARKET, BY PRODUCT: MARKET SHARE 2019 (%)
  • FIGURE 120 UAE RADIOTHERAPY MARKET, BY PRODUCT: MARKET SHARE 2019 (%)
  • FIGURE 121 UAE EXTERNAL BEAM RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT: MARKET SHARE 2019 (%)
  • FIGURE 122 UAE INTERNAL RADIOTHERAPY PRODUCTS IN RADIOTHERAPY MARKET, BY PRODUCT: MARKET SHARE 2019 (%)
  • FIGURE 123 EGYPT RADIOTHERAPY MARKET, BY PRODUCT: MARKET SHARE 2019 (%)
  • FIGURE 124 EGYPT EXTERNAL BEAM RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT: MARKET SHARE 2019 (%)
  • FIGURE 125 EGYPT INTERNAL RADIOTHERAPY PRODUCTS IN RADIOTHERAPY MARKET, BY PRODUCT: MARKET SHARE 2019 (%)
  • FIGURE 126 ISRAEL RADIOTHERAPY MARKET, BY PRODUCT: MARKET SHARE 2019 (%)
  • FIGURE 127 ISRAEL EXTERNAL BEAM RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT: MARKET SHARE 2019 (%)
  • FIGURE 128 ISRAEL INTERNAL RADIOTHERAPY PRODUCTS IN RADIOTHERAPY MARKET, BY PRODUCT: MARKET SHARE 2019 (%)
  • FIGURE 129 GLOBAL PROTON BEAM THERAPY IN RADIOTHERAPY MARKET: COMPANY SHARE 2019 (%)
  • FIGURE 130 NORTH PROTON BEAM THERAPY IN RADIOTHERAPY MARKET: COMPANY SHARE 2019 (%)
  • FIGURE 131 U.S. PROTON BEAM THERAPY IN RADIOTHERAPY MARKET: COMPANY SHARE 2019 (%)
  • FIGURE 132 CANADA PROTON BEAM THERAPY IN RADIOTHERAPY MARKET: COMPANY SHARE 2019 (%)
  • FIGURE 133 EUROPE PROTON BEAM THERAPY IN RADIOTHERAPY MARKET: COMPANY SHARE 2019 (%)
  • FIGURE 134 GERMANY PROTON BEAM THERAPY IN RADIOTHERAPY MARKET: COMPANY SHARE 2019 (%)
  • FIGURE 135 FRANCE PROTON BEAM THERAPY IN RADIOTHERAPY MARKET: COMPANY SHARE 2019 (%)
  • FIGURE 136 ITALY PROTON BEAM THERAPY IN RADIOTHERAPY MARKET: COMPANY SHARE 2019 (%)
  • FIGURE 137 U.K. PROTON BEAM THERAPY IN RADIOTHERAPY MARKET: COMPANY SHARE 2019 (%)
  • FIGURE 138 SPAIN PROTON BEAM THERAPY IN RADIOTHERAPY MARKET: COMPANY SHARE 2019 (%)
  • FIGURE 139 ASIA-PACIFIC PROTON BEAM THERAPY IN RADIOTHERAPY MARKET: COMPANY SHARE 2019 (%)
  • FIGURE 140 CHINA PROTON BEAM THERAPY IN RADIOTHERAPY MARKET: COMPANY SHARE 2019 (%)
  • FIGURE 141 JAPAN PROTON BEAM THERAPY IN RADIOTHERAPY MARKET: COMPANY SHARE 2019 (%)
  • FIGURE 142 INDIA PROTON BEAM THERAPY IN RADIOTHERAPY MARKET: COMPANY SHARE 2019 (%)
  • FIGURE 143 SOUTH KOREA PROTON BEAM THERAPY IN RADIOTHERAPY MARKET: COMPANY SHARE 2019 (%)
  • FIGURE 144 GLOBAL BRACHYTHERAPY IN RADIOTHERAPY MARKET: COMPANY SHARE 2019 (%)
  • FIGURE 145 NORTH BRACHYTHERAPY IN RADIOTHERAPY MARKET: COMPANY SHARE 2019 (%)
  • FIGURE 146 U.S. BRACHYTHERAPY IN RADIOTHERAPY MARKET: COMPANY SHARE 2019 (%)
  • FIGURE 147 CANADA BRACHYTHERAPY IN RADIOTHERAPY MARKET: COMPANY SHARE 2019 (%)
  • FIGURE 148 EUROPE BRACHYTHERAPY IN RADIOTHERAPY MARKET: COMPANY SHARE 2019 (%)
  • FIGURE 149 GERMANY BRACHYTHERAPY IN RADIOTHERAPY MARKET: COMPANY SHARE 2019 (%)
  • FIGURE 150 FRANCE BRACHYTHERAPY IN RADIOTHERAPY MARKET: COMPANY SHARE 2019 (%)
  • FIGURE 151 ITALY BRACHYTHERAPY IN RADIOTHERAPY MARKET: COMPANY SHARE 2019 (%)
  • FIGURE 152 U.K. BRACHYTHERAPY IN RADIOTHERAPY MARKET: COMPANY SHARE 2019 (%)
  • FIGURE 153 SPAIN BRACHYTHERAPY IN RADIOTHERAPY MARKET: COMPANY SHARE 2019 (%)
  • FIGURE 154 ASIA-PACIFIC BRACHYTHERAPY IN RADIOTHERAPY MARKET: COMPANY SHARE 2019 (%)
  • FIGURE 155 CHINA BRACHYTHERAPY IN RADIOTHERAPY MARKET: COMPANY SHARE 2019 (%)
  • FIGURE 156 JAPAN BRACHYTHERAPY IN RADIOTHERAPY MARKET: COMPANY SHARE 2019 (%)
  • FIGURE 157 INDIA BRACHYTHERAPY IN RADIOTHERAPY MARKET: COMPANY SHARE 2019 (%)
  • FIGURE 158 SOUTH KOREA BRACHYTHERAPY IN RADIOTHERAPY MARKET: COMPANY SHARE 2019 (%)
  • FIGURE 159 GLOBAL IMAGE-GUIDED RADIATION THERAPY (IGRT) IN RADIOTHERAPY MARKET: COMPANY SHARE 2019 (%)
  • FIGURE 160 NORTH IMAGE-GUIDED RADIATION THERAPY (IGRT) IN RADIOTHERAPY MARKET: COMPANY SHARE 2019 (%)
  • FIGURE 161 U.S. IMAGE-GUIDED RADIATION THERAPY (IGRT) IN RADIOTHERAPY MARKET: COMPANY SHARE 2019 (%)
  • FIGURE 162 CANADA IMAGE-GUIDED RADIATION THERAPY (IGRT) IN RADIOTHERAPY MARKET: COMPANY SHARE 2019 (%)
  • FIGURE 163 EUROPE IMAGE-GUIDED RADIATION THERAPY (IGRT) IN RADIOTHERAPY MARKET: COMPANY SHARE 2019 (%)
  • FIGURE 164 GERMANY IMAGE-GUIDED RADIATION THERAPY (IGRT) IN RADIOTHERAPY MARKET: COMPANY SHARE 2019 (%)
  • FIGURE 165 FRANCE IMAGE-GUIDED RADIATION THERAPY (IGRT) IN RADIOTHERAPY MARKET: COMPANY SHARE 2019 (%)
  • FIGURE 166 ITALY IMAGE-GUIDED RADIATION THERAPY (IGRT) IN RADIOTHERAPY MARKET: COMPANY SHARE 2019 (%)
  • FIGURE 167 U.K. IMAGE-GUIDED RADIATION THERAPY (IGRT) IN RADIOTHERAPY MARKET: COMPANY SHARE 2019 (%)
  • FIGURE 168 SPAIN IMAGE-GUIDED RADIATION THERAPY (IGRT) IN RADIOTHERAPY MARKET: COMPANY SHARE 2019 (%)
  • FIGURE 169 ASIA-PACIFIC IMAGE-GUIDED RADIATION THERAPY (IGRT) IN RADIOTHERAPY MARKET: COMPANY SHARE 2019 (%)
  • FIGURE 170 CHINA IMAGE-GUIDED RADIATION THERAPY (IGRT) IN RADIOTHERAPY MARKET: COMPANY SHARE 2019 (%)
  • FIGURE 171 JAPAN IMAGE-GUIDED RADIATION THERAPY (IGRT) IN RADIOTHERAPY MARKET: COMPANY SHARE 2019 (%)
  • FIGURE 172 INDIA IMAGE-GUIDED RADIATION THERAPY (IGRT) IN RADIOTHERAPY MARKET: COMPANY SHARE 2019 (%)
  • FIGURE 173 SOUTH KOREA IMAGE-GUIDED RADIATION THERAPY (IGRT) IN RADIOTHERAPY MARKET: COMPANY SHARE 2019 (%)
  • FIGURE 174 GLOBAL STEREOTACTIC RADIATION THERAPY IN RADIOTHERAPY MARKET: COMPANY SHARE 2019 (%)
  • FIGURE 175 NORTH STEREOTACTIC RADIATION THERAPY IN RADIOTHERAPY MARKET: COMPANY SHARE 2019 (%)
  • FIGURE 176 U.S. STEREOTACTIC RADIATION THERAPY IN RADIOTHERAPY MARKET: COMPANY SHARE 2019 (%)
  • FIGURE 177 CANADA STEREOTACTIC RADIATION THERAPY IN RADIOTHERAPY MARKET: COMPANY SHARE 2019 (%)
  • FIGURE 178 EUROPE STEREOTACTIC RADIATION THERAPY IN RADIOTHERAPY MARKET: COMPANY SHARE 2019 (%)
  • FIGURE 179 GERMANY STEREOTACTIC RADIATION THERAPY IN RADIOTHERAPY MARKET: COMPANY SHARE 2019 (%)
  • FIGURE 180 FRANCE STEREOTACTIC RADIATION THERAPY IN RADIOTHERAPY MARKET: COMPANY SHARE 2019 (%)
  • FIGURE 181 ITALY STEREOTACTIC RADIATION THERAPY IN RADIOTHERAPY MARKET: COMPANY SHARE 2019 (%)
  • FIGURE 182 U.K. STEREOTACTIC RADIATION THERAPY IN RADIOTHERAPY MARKET: COMPANY SHARE 2019 (%)
  • FIGURE 183 SPAIN STEREOTACTIC RADIATION THERAPY IN RADIOTHERAPY MARKET: COMPANY SHARE 2019 (%)
  • FIGURE 184 ASIA-PACIFIC STEREOTACTIC RADIATION THERAPY IN RADIOTHERAPY MARKET: COMPANY SHARE 2019 (%)
  • FIGURE 185 CHINA STEREOTACTIC RADIATION THERAPY IN RADIOTHERAPY MARKET: COMPANY SHARE 2019 (%)
  • FIGURE 186 JAPAN STEREOTACTIC RADIATION THERAPY IN RADIOTHERAPY MARKET: COMPANY SHARE 2019 (%)
  • FIGURE 187 INDIA STEREOTACTIC RADIATION THERAPY IN RADIOTHERAPY MARKET: COMPANY SHARE 2019 (%)
  • FIGURE 188 SOUTH KOREA STEREOTACTIC RADIATION THERAPY IN RADIOTHERAPY MARKET: COMPANY SHARE 2019 (%)
  • FIGURE 189 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF GLOBAL RADIOTHERAPY MARKET
  • FIGURE 190 CANCER DEATH RATES BY AGE GROUP (2017)
  • FIGURE 191 NUMBER OF NEW CANCER CASES IN 2018, ALL AGES
  • FIGURE 192 NUMBER OF NEW CASES IN 2018, IN MALES, ALL AGES
  • FIGURE 193 NUMBER OF NEW CASES IN 2018, IN FEMALES, ALL AGES
  • FIGURE 194 ESTIMATED LIFETIME CARE SPENDING
  • FIGURE 195 OUT OF POCKET COSTS DURING CANCER
  • FIGURE 196 HEALTH SPENDING BY MAJOR SOURCES OF FUNDS
  • FIGURE 197 GLOBAL RADIOTHERAPY MARKET: BY TYPE, 2019
  • FIGURE 198 GLOBAL RADIOTHERAPY MARKET, BY TYPE, 2019-2027 (USD MILLION)
  • FIGURE 199 GLOBAL RADIOTHERAPY MARKET: BY TYPE, CAGR (2020-2027)
  • FIGURE 200 GLOBAL RADIOTHERAPY MARKET: BY TYPE, LIFELINE CURVE
  • FIGURE 201 GLOBAL RADIOTHERAPY MARKET: BY PRODUCT, 2019
  • FIGURE 202 GLOBAL RADIOTHERAPY MARKET, BY PRODUCT, 2019-2027 (USD MILLION)
  • FIGURE 203 GLOBAL RADIOTHERAPY MARKET: BY PRODUCT, CAGR (2020-2027)
  • FIGURE 204 GLOBAL RADIOTHERAPY MARKET: BY PRODUCT, LIFELINE CURVE
  • FIGURE 205 GLOBAL RADIOTHERAPY MARKET: BY APPLICATION, 2019
  • FIGURE 206 GLOBAL RADIOTHERAPY MARKET, BY APPLICATION, 2019-2027 (USD MILLION)
  • FIGURE 207 GLOBAL RADIOTHERAPY MARKET: BY APPLICATION, CAGR (2020-2027)
  • FIGURE 208 GLOBAL RADIOTHERAPY MARKET: BY APPLICATION, LIFELINE CURVE
  • FIGURE 209 GLOBAL RADIOTHERAPY MARKET: BY END USER, 2019
  • FIGURE 210 GLOBAL RADIOTHERAPY MARKET, BY END USER, 2019-2027 (USD MILLION)
  • FIGURE 211 GLOBAL RADIOTHERAPY MARKET: BY END USER, CAGR (2020-2027)
  • FIGURE 212 GLOBAL RADIOTHERAPY MARKET: BY END USER, LIFELINE CURVE
  • FIGURE 213 GLOBAL RADIOTHERAPY MARKET: BY DISTRIBUTION CHANNEL, 2019
  • FIGURE 214 GLOBAL RADIOTHERAPY MARKET, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
  • FIGURE 215 GLOBAL RADIOTHERAPY MARKET: BY DISTRIBUTION CHANNEL, CAGR (2020-2027)
  • FIGURE 216 GLOBAL RADIOTHERAPY MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
  • FIGURE 217 GLOBAL RADIOTHERAPY MARKET: SNAPSHOT (2019)
  • FIGURE 218 GLOBAL RADIOTHERAPY MARKET: BY COUNTRY (2019)
  • FIGURE 219 GLOBAL RADIOTHERAPY MARKET: BY COUNTRY (2020 & 2027)
  • FIGURE 220 GLOBAL RADIOTHERAPY MARKET: BY COUNTRY (2019 & 2027)
  • FIGURE 221 GLOBAL RADIOTHERAPY MARKET: BY TYPE (2020-2027)
  • FIGURE 222 NORTH AMERICA RADIOTHERAPY MARKET: SNAPSHOT (2019)
  • FIGURE 223 NORTH AMERICA RADIOTHERAPY MARKET: BY COUNTRY (2019)
  • FIGURE 224 NORTH AMERICA RADIOTHERAPY MARKET: BY COUNTRY (2020 & 2027)
  • FIGURE 225 NORTH AMERICA RADIOTHERAPY MARKET: BY COUNTRY (2020 & 2027)
  • FIGURE 226 NORTH AMERICA RADIOTHERAPY MARKET: BY TYPE (2018-2027)
  • FIGURE 227 EUROPE RADIOTHERAPY MARKET: SNAPSHOT (2019)
  • FIGURE 228 EUROPE RADIOTHERAPY MARKET: BY COUNTRY (2019)
  • FIGURE 229 EUROPE RADIOTHERAPY MARKET: BY COUNTRY (2020 & 2027)
  • FIGURE 230 EUROPE RADIOTHERAPY MARKET: BY COUNTRY (2020 & 2027)
  • FIGURE 231 EUROPE RADIOTHERAPY MARKET: BY TYPE (2018-2027)
  • FIGURE 232 ASIA-PACIFIC RADIOTHERAPY MARKET: SNAPSHOT (2019)
  • FIGURE 233 ASIA-PACIFIC RADIOTHERAPY MARKET: BY COUNTRY (2019)
  • FIGURE 234 ASIA-PACIFIC RADIOTHERAPY MARKET: BY COUNTRY (2020 & 2027)
  • FIGURE 235 ASIA-PACIFIC RADIOTHERAPY MARKET: BY COUNTRY (2020 & 2027)
  • FIGURE 236 ASIA-PACIFIC RADIOTHERAPY MARKET: BY TYPE (2018-2027)
  • FIGURE 237 SOUTH AMERICA RADIOTHERAPY MARKET: SNAPSHOT (2019)
  • FIGURE 238 SOUTH AMERICA RADIOTHERAPY MARKET: BY COUNTRY (2019)
  • FIGURE 239 SOUTH AMERICA RADIOTHERAPY MARKET: BY COUNTRY (2020 & 2027)
  • FIGURE 240 SOUTH AMERICA RADIOTHERAPY MARKET: BY COUNTRY (2020 & 2027)
  • FIGURE 241 SOUTH AMERICA RADIOTHERAPY MARKET: BY TYPE (2018-2027)
  • FIGURE 242 MIDDLE EAST AND AFRICA RADIOTHERAPY MARKET: SNAPSHOT (2019)
  • FIGURE 243 MIDDLE EAST AND AFRICA RADIOTHERAPY MARKET: BY COUNTRY (2019)
  • FIGURE 244 MIDDLE EAST AND AFRICA RADIOTHERAPY MARKET: BY COUNTRY (2020 & 2027)
  • FIGURE 245 MIDDLE EAST AND AFRICA RADIOTHERAPY MARKET: BY COUNTRY (2020 & 2027)
  • FIGURE 246 MIDDLE EAST AND AFRICA RADIOTHERAPY MARKET: BY TYPE (2018-2027)
  • FIGURE 247 GLOBAL RADIOTHERAPY MARKET: COMPANY SHARE 2019 (%)
  • FIGURE 248 NORTH AMERICA RADIOTHERAPY MARKET: COMPANY SHARE 2019 (%)
  • FIGURE 249 EUROPE RADIOTHERAPY MARKET: COMPANY SHARE 2019 (%)
  • FIGURE 250 ASIA-PACIFIC RADIOTHERAPY MARKET: COMPANY SHARE 2019 (%)